Search results
US Economy News Today: Mortgage Demand Moves Up Again as Rates Hit 7-Week Low
Investopedia· 1 hour agoToday, we will see if existing home sales have risen and the Federal Open Markets Committee meeting...
Tornadoes in Iowa and what's next in Trump's trial: Morning Rundown
NBC News via Yahoo News· 55 minutes agoDevastating tornadoes in Iowa left several dead. And a new study finds teens who use cannabis are...
Starbucks: The Quality Remains
GuruFocus.com via Yahoo Finance· 2 minutes agoIt is not hard to see Starbucks is a high-quality business with a legitimately wide moat. The price today is a bit much for me, but the company fits my...
Chad Daybell trial live: Forensic pathologist says Tammy Daybell’s death should have been...
The Independent via Yahoo News· 24 minutes agoThe defense will continue with a new witness on Wednesday at 10:30am ET / 8:30am MT. Today, the...
McDonald's Grandma McFlurry Is Bursting With Butterscotch
Daily Meal via Yahoo News· 1 hour agoJust in time for summers at Grandma's house, McDonald's has released the limited-time-only...
Biden is forgiving $7.7 billion in student debt. Here's who qualifies.
CBS News· 50 minutes agoThe White House on Wednesday said it has approved $7.7 billion of student debt cancellation for...
Shopify, Kraft Heinz upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 25 minutes agoHere are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades:...
Zacks Investment Ideas feature highlights: Coinbase, Robinhood, Reddit, GameStop and MicroStrategy
Zacks via Yahoo Finance· 4 hours agoSince 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year....
Q4 2024 Viasat Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 21 minutes agoMark D. Dankberg Good afternoon, and thanks for joining us today. With me, I have Guru Gowrappan, our President; and Shawn Duffy, our CFO... acquisition, dealt with the satellite ...
Is CRISPR Therapeutics a Millionaire Maker?
The Motley Fool via AOL· 52 minutes agoThere won't be any shortage of growth in the near term. Looking a bit further out, CRISPR Therapeutics has plenty of promising pipeline programs that could drive more growth ...
